Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,168
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
for
Cardiomyopathies, Heart Failure
Location: Cincinnati OH, McKinney TX
Sponsor: Zoll Medical Corporation
Sex: Female
Age: 18+
Code: NCT04504188
Recruiting
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
for
Treatment-resistant Depression (TRD)
Location: Cincinnati OH, Indianapolis IN, Garfield Heights OH,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70+
Code: NCT07553637
Phase 2, Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Cincinnati OH, Winston-Salem NC, St Louis MO,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase 2, Recruiting
Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
for
Angioedema
Location: Cincinnati OH
Sponsor: Bernstein Clinical Research Center
Sex: All
Age: 18+
Code: NCT06818474
Recruiting
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
for
Urticaria Chronic
Location: Cincinnati OH, Glenview IL
Sponsor: ARS Pharmaceuticals, Inc.
Sex: All
Age: 18 - 65
Code: NCT06927999
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.
for
Any Solid Oral Medication
Location: Cincinnati OH
Sponsor: Dosentrx Ltd.
Sex: All
Age: 18+
Code: NCT06335758
Recruiting
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Cincinnati OH, Franklin OH, Centerville OH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase 2, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Cincinnati OH, Franklin OH, Centerville OH,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT06470243
Phase 3, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
ALTO-100 in Bipolar Disorder With Depression (BD-D)
for
Bipolar Disorder I or II With a Major Depressive Episode
Location: Cincinnati OH, Carmel IN, Westlake OH, Ann Arbor MI,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT06656416
Phase 2, Recruiting
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
for
Psoriatic Arthritis
Location: Blue Ash OH, Wheelersburg OH, Crossville TN, Lilburn GA,
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 70+
Code: NCT05669833
Phase 3, Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Florence KY, Indianapolis IN, Bowling Green KY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase 2, Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for
Epithelial Ovarian Cancer
Location: Blue Ash OH, Dayton OH, Louisville KY, Indianapolis IN,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07218809
Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Blue Ash OH, Lexington KY, Columbus OH, Marion OH,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase 3, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7